Turkey Drives Sales Growth For Zentiva

Czech generics specialist Zentiva has said it expects sales to reach CZK8.9bn for the first half of 2008, a 32% year-on-year (y-o-y) growth. A continuing decline in sales in its key markets of Czech Republic and Romania was buffered by inclusion of sales from Eczacibaşi, the Turkish firm acquired by Zentiva in

To read the full article, please choose one of the following options: